Works matching DE "PULMONARY hypertension treatment"


Results: 922
    1
    3
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Curcumin analogues inhibit phosphodiesterase-5 and dilate rat pulmonary arteries.

    Published in:
    Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 1, p. 87, doi. 10.1111/jphp.12302
    By:
    • Kruangtip, Oraya;
    • Chootip, Krongkarn;
    • Temkitthawon, Prapapan;
    • Changwichit, Kanokwan;
    • Chuprajob, Thipphawan;
    • Changtam, Chatchawan;
    • Suksamrarn, Apichart;
    • Khorana, Nantaka;
    • Scholfield, C. Norman;
    • Ingkaninan, Kornkanok
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Association between Leflunomide and Pulmonary Hypertension.

    Published in:
    2021
    By:
    • Palasset, Thomas Lacoste;
    • Chaumais, Marie-Camille;
    • Weatherald, Jason;
    • Savale, Laurent;
    • Jaïs, Xavier;
    • Price, Laura C.;
    • Khouri, Charles;
    • Bulifon, Sophie;
    • Seferian, Andrei;
    • Jevnikar, Mitja;
    • Boucly, Athénaïs;
    • Manaud, Grégoire;
    • Pancic, Stefana;
    • Chabanne, Celine;
    • Ahmad, Kaïs;
    • Volpato, Mathilde;
    • Favrolt, Nicolas;
    • Guillaumot, Anne;
    • Horeau-Langlard, Delphine;
    • Prévot, Grégoire
    Publication type:
    journal article
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Role of prostacyclin in pulmonary hypertension.

    Published in:
    Global Cardiology Science & Practice, 2014, v. 2014, n. 4, p. 214, doi. 10.5339/gcsp.2014.53
    By:
    • Mitchell, Jane A.;
    • Ahmetaj-Shala, Blerina;
    • Kirkby, Nicholas S.;
    • Wright, William R.;
    • Mackenzie, Louise S.;
    • Reed, Daniel M.;
    • Mohamed, Nura
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.

    Published in:
    Frontiers in Physiology, 2018, p. 1, doi. 10.3389/fphys.2018.00180
    By:
    • Rathinasabapathy, Anandharajan;
    • Horowitz, Alana;
    • Horton, Kelsey;
    • Kumar, Ashok;
    • Gladson, Santhi;
    • Unger, Thomas;
    • Martinez, Diana;
    • Bedse, Gaurav;
    • West, James;
    • Raizada, Mohan K.;
    • Steckelings, Ulrike M.;
    • Sumners, Colin;
    • Katovich, Michael J.;
    • Shenoy, Vinayak
    Publication type:
    Article
    45
    46
    47
    48
    49
    50